INNT - Innovate Biopharmaceuticals Inc.
Previous close
0.56
0.560 100.000%
Share volume: 0
Last Updated: Fri 01 May 2020 10:00:01 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
21%
Profitability
20%
Dept financing
49%
Liquidity
5%
Performance
19%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.86%
Return on assets
-50.71%
Return on sales
-468.58%
Return on invested capital
95.7%
Total debt ratio
113.31%
Debt ratio change over timeo
2.06%
Current Ratio
0.97%
Quick Ratio
0.4%
Cash Position Ratio
0.7%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-121.29%
Return on assets
-27.64%
Return on sales
0%
Return on invested capital
32.05%
Total debt ratio
101.32%
Debt ratio change over timeo
4.71%
Current Ratio
1.08%
Quick Ratio
0%
Cash Position Ratio
1%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-89.65%
Return on assets
-41.83%
Return on sales
0%
Return on invested capital
47.2%
Total debt ratio
65.8%
Debt ratio change over time
0.59%
Current Ratio
1.51%
Quick Ratio
0%
Cash Position Ratio
1.39%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-139.28%
Return on assets
-206.34%
Return on sales
-531.58%
Return on invested capital
42.25%
Total debt ratio
206.25%
Debt ratio change over time
2.06%
Current Ratio
0.95%
Quick Ratio
-0.55%
Cash Position Ratio
0.74%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INNT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -8.86% | -5.61% | -10.5% | -11.67% |
| Return on assets | -50.71% | -20.86% | -8.18% | -9.47% |
| Return on sales | -468.58% | -5539.23% | 0% | -356.65% |
| Return on invested capital | 95.7% | 354.56% | -245.62% | -123.06% |
| Profitability | 7% | 50% | 50% | 0% |
| Total debt ratio | 113.31% | 135.51% | 24.76% | 24.16% |
| Debt ratio change over time | 2.06% | 0.12% | -1.08% | -1.38% |
| Dept financing | 46% | 26% | 5% | 4% |
| Current Ratio | 1.08% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 1% | 11.51% | 3.1% | 1.63% |
| Liquididy | 6% | 46% | 25% | 59% |
| Short-term ratios | INNT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -121.29% | -42.29% | -17.27% | -12.45% |
| Return on assets | -27.64% | -16.67% | -11.14% | -7.48% |
| Return on sales | 0% | 0% | 0% | -422.62% |
| Return on invested capital | 32.05% | 675.1% | -305.46% | -38.28% |
| Profitability | 26% | 25% | 0% | 50% |
| Total debt ratio | 101.32% | 57.87% | 25.5% | 39.42% |
| Debt ratio change over time | 4.71% | -0.87% | -1.62% | -1.81% |
| Dept financing | 50% | 14% | 6% | 10% |
| Current Ratio | 1.08% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 1% | 11.51% | 3.1% | 1.63% |
| Liquididy | 4% | 50% | 22% | 45% |